Patents-Review.com
🔗 Permalink
Assignee profile:

CELLECTIS S.A.

City:

Paris

Country:

France

Published Applications:

31

Last publication date:

2025-01-23

Patent Grants:

19

Last grant date:

2024-11-05

Top Inventors for applications by CELLECTIS S.A.

These are the the leading inventors for applications assigned to CELLECTIS S.A.:

Recent patent applications by CELLECTIS S.A.

CELLECTIS S.A. based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-01-23
US20250026808A1
Chemistry; metallurgy

UNIVERSAL ANTI-CD22 CHIMERIC ANTIGEN RECEPTOR ENGINEERED IMMUNE CELLS

 #2 | 2024-06-13 ✅ Patent 12,133,867 granted on 2024-11-05
US20240189354A1
Human necessities

Universal anti-CD22 chimeric antigen receptor engineered immune cells

 #3 | 2023-09-07 ✅ Patent 12,534,744 granted on 2026-01-27
US20230279440A1
Chemistry; metallurgy

METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PROTEINS

 #4 | 2023-09-07 ✅ Patent 12,618,048 granted on 2026-05-05
US20230279350A1
Chemistry; metallurgy

DUAL CAR-T CELLS

 #5 | 2021-06-03 ✅ Patent 11,944,643 granted on 2024-04-02
US20210161954A1
Human necessities

Universal anti-CD22 chimeric antigen receptor engineered immune cells

 #6 | 2021-04-08 ✅ Patent 11,690,873 granted on 2023-07-04
US20210100839A1
Human necessities

Universal chimeric antigen receptor T cells specific for CD22

 #7 | 2021-03-04 ✅ Patent 11,576,317 granted on 2023-02-14
US20210059142A1
Human necessities

Mutant plant or cell with reduced XylT and FucT

 #8 | 2018-08-23 ✅ Patent 11,578,318 granted on 2023-02-14
US20180237765A1
Chemistry; metallurgy

Large volume ex vivo electroporation method

 #9 | 2016-10-20 ✅ Patent 10,202,579 granted on 2019-02-12
US20160304834A1
Chemistry; metallurgy

Methods for producing mammalian pluripotent stem cell-derived endodermal cells

 #10 | 2015-10-01 ✅ Patent 11,555,198 granted on 2023-01-17
US20150272076A1
Human necessities

Method for making nicotiana plants with mutations in XylT and FucT alleles using rare-cutting endonucleases

 #11 | 2015-08-06 ✅ Patent 10,378,007 granted on 2019-08-13
US20150218230A1
Chemistry; metallurgy

Methods for modulating TAL specificity

 #12 | 2015-03-05 ✅ Patent 11,778,993 granted on 2023-10-10
US20150067900A1
Human necessities

Repeat variable diresidues for targeting nucleotides

 #13 | 2014-10-16
US20140309145A1
Chemistry; metallurgy

HIGH THROUGHPUT METHOD FOR ASSEMBLY AND CLONING POLYNUCLEOTIDES COMPRISING HIGHLY SIMILAR POLYNUCLEOTIDIC MODULES

 #14 | 2014-05-01
US20140120578A1
Chemistry; metallurgy

PLANTS FOR PRODUCTION OF THERAPEUTIC PROTEINS

 #15 | 2013-12-05
US20130326644A1
Chemistry; metallurgy

LAGLIDADG HOMING ENDONUCLEASE VARIANTS HAVING MUTATIONS IN TWO FUNCTIONAL SUBDOMAINS AND USE THEREOF

 #16 | 2013-08-08
US20130203840A1
Human necessities

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

 #17 | 2013-05-09 ✅ Patent 9,315,788 granted on 2016-04-19
US20130117869A1
Chemistry; metallurgy

Method for the generation of compact TALE-nucleases and uses thereof

 #18 | 2013-03-14
US20130067607A1
Chemistry; metallurgy

MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM A RAG GENE AND USES THEREOF

 #19 | 2013-03-07
US20130061341A1
Chemistry; metallurgy

MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM A XP GENE AND USES THEREOF

 #20 | 2012-12-27
US20120331574A1
Chemistry; metallurgy

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

 #21 | 2012-12-20
US20120322689A1
Chemistry; metallurgy

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

 #22 | 2012-12-13 ✅ Patent 8,624,000 granted on 2014-01-07
US20120317664A1
Chemistry; metallurgy

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

 #23 | 2012-11-29
US20120304321A1
Chemistry; metallurgy

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

 #24 | 2012-11-15
US20120288943A1
Chemistry; metallurgy

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

 #25 | 2012-11-15
US20120288942A1
Chemistry; metallurgy

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

 #26 | 2012-11-15 ✅ Patent 8,697,395 granted on 2014-04-15
US20120288941A1
Chemistry; metallurgy

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

 #27 | 2012-06-26 ✅ Patent 8,206,965 granted on 2012-06-26
US10388230
-

Hybrid and single chain meganucleases and use thereof

 #28 | 2011-11-24 ✅ Patent 8,530,214 granted on 2013-09-10
US20110287513A1
Chemistry; metallurgy

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

 #29 | 2011-07-21 ✅ Patent 8,927,247 granted on 2015-01-06
US20110179506A1
Chemistry; metallurgy

I-I derived single-chain meganuclease and uses thereof

 #30 | 2010-02-25 ✅ Patent 8,293,701 granted on 2012-10-23
US20100047260A1
Human necessities

Methods and compositions relating to a vaccine against prostate cancer

 #31 | 2006-08-29 ✅ Patent 7,098,031 granted on 2006-08-29
US10242664
-

Random integration of a polynucleotide by in vivo linearization

Also check out CELLECTIS, S.A.'s (Paris, France) applicant profile with 23 patent applications submitted.

AssigneeID:

13175 ⎘